Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vermylen

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Developments in Biological Standardization|January 1, 1980
The Belgian plasmapheresis programmeC Vermylen
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1970
The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulinsC Vermylen
Blood Reviews|March 1, 1993
Bone marrow transplantation in sickle cell anaemiaC Vermylen, G Cornu
The American Journal of Pediatric Hematology/Oncology|February 1, 1994
Bone marrow transplantation for sickle cell disease. The European experienceC Vermylen, G Cornu
Current Opinion in Hematology|March 1, 1996
Bone marrow transplantation for sickle cell anemiaC Vermylen, G Cornu
Current Opinion in Hematology|November 14, 1997
Hematopoietic stem cell transplantation for sickle cell anemiaC Vermylen, G Cornu
Haematologica|November 4, 2008
Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysisA K Lukusa, C Vermylen
Lancet (London, England)|October 16, 1971
Choriocarcinoma and HL-A antigensI Van de Putte, C Vermylen
Medical Hypotheses|October 1, 1988
HIV1-virus is not inactivated by buthylated hydroxytoluene (BHT) in vitroH Claeys, M Mercken, C Vermylen
Acta Clinica Belgica|January 1, 1990
Treatment of immune thrombocytopaenic purpura in childhood. A review of 146 patientsC Vermylen, F Bugnon, J Ninane, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Developments in Biological Standardization|January 1, 1980
The Belgian plasmapheresis programmeC Vermylen
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1970
The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulinsC Vermylen
Blood Reviews|March 1, 1993
Bone marrow transplantation in sickle cell anaemiaC Vermylen, G Cornu
The American Journal of Pediatric Hematology/Oncology|February 1, 1994
Bone marrow transplantation for sickle cell disease. The European experienceC Vermylen, G Cornu
Current Opinion in Hematology|March 1, 1996
Bone marrow transplantation for sickle cell anemiaC Vermylen, G Cornu
Current Opinion in Hematology|November 14, 1997
Hematopoietic stem cell transplantation for sickle cell anemiaC Vermylen, G Cornu
Haematologica|November 4, 2008
Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysisA K Lukusa, C Vermylen
Lancet (London, England)|October 16, 1971
Choriocarcinoma and HL-A antigensI Van de Putte, C Vermylen
Medical Hypotheses|October 1, 1988
HIV1-virus is not inactivated by buthylated hydroxytoluene (BHT) in vitroH Claeys, M Mercken, C Vermylen
Acta Clinica Belgica|January 1, 1990
Treatment of immune thrombocytopaenic purpura in childhood. A review of 146 patientsC Vermylen, F Bugnon, J Ninane, et al.
Pageof 11